Manufacturer or GPO Program year 2023 Source: CMS Open Payments

Avinger Inc.

CA, United States

CMS manufacturer 100000010573

Open in the dashboard

General payments

$322,391

3,221 payments

Research payments

$0

0 payments

Ownership & investment interest

$0

None reported

Through program year 2023, Avinger Inc. reported paying $322,391 in general payments and $0 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2023 General $28,569 657
2022 General $85,442 649
2021 General $149,731 794
2020 General $17,069 400
2019 General $41,580 721

Breakdown

Top recipients General payments · program year 2023
  1. Ian Cawich Cardiovascular Disease · Little Rock, AR $3,768 110 payments
  2. Dwight Dishmon Interventional Cardiology · Memphis, TN $1,630 50 payments
  3. Thomas Davis Cardiovascular Disease · St Clair Shores, MI $1,130 19 payments
  4. Michael Lieb Vascular Surgery · Hainesport, NJ $693 12 payments
  5. Luai Tabaza Interventional Cardiology · Cherry Hill, NJ $600 12 payments
  6. Jeffrey Stewart Cardiovascular Disease · Little Rock, AR $571 8 payments
  7. Sharat Koul Interventional Cardiology · Nicholasville, KY $514 10 payments
  8. Venkata Gadi Interventional Cardiology · Baton Rouge, LA $484 9 payments
  9. Jon George Interventional Cardiology · Philadelphia, PA $468 6 payments
  10. Sean Janzer Interventional Cardiology · York, PA $461 5 payments
Products the payments named General payments · program year 2023
  1. Pantheris Vascular $28,569 100% · 232 recipients

Each share is of this company’s general payments naming a product in 2023. A payment can name up to five products, so these amounts overlap.

Specialties paid General payments · program year 2023
  1. Interventional Cardiology Internal Medicine $10,558 37% · 63 practitioners
  2. Cardiovascular Disease Internal Medicine $8,250 29% · 35 practitioners
  3. Vascular Surgery Surgery $3,842 13% · 46 practitioners
  4. Nurse Practitioner $932 3% · 10 practitioners
  5. Surgery $742 3% · 14 practitioners

The top 5 of 25 specialties; each share is of this company’s general payments to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. Arkansas $7,661 27% · 29 recipients
  2. Texas $4,498 16% · 61 recipients
  3. New Jersey $4,093 14% · 21 recipients
  4. Tennessee $2,732 10% · 20 recipients
  5. Pennsylvania $2,164 8% · 11 recipients

The top 5 of 20 states; each share is of this company’s general payments in 2023 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $144,993 3,089 payments
  2. Honoraria $123,063 32 payments
  3. Travel and Lodging $54,335 100 payments
3,221 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record